These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33505384)

  • 21. Comparative pharmacokinetics of florfenicol in healthy and Pasteurella multocida-infected Gaoyou ducks.
    Lan W; Xiao X; Jiang Y; Jiang L; Zhao X; Yu Z; Zhu B; Li C; Bian L; Wang Z
    J Vet Pharmacol Ther; 2019 May; 42(3):355-360. PubMed ID: 30912167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli.
    Xiao X; Chen X; Yan K; Jiang L; Li R; Liu Y; Wang M; Wang Z
    J Vet Pharmacol Ther; 2022 Jan; 45(1):83-91. PubMed ID: 34469000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against
    Lei Z; Liu Q; Xiong J; Yang B; Yang S; Zhu Q; Li K; Zhang S; Cao J; He Q
    Front Pharmacol; 2017; 8():542. PubMed ID: 28871226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis.
    Xiao X; Sun J; Chen Y; Huang RJ; Huang T; Qiao GG; Zhou YF; Liu YH
    BMC Vet Res; 2015 Feb; 11():33. PubMed ID: 25889187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PK/PD integration of florfenicol alone and in combination with doxycycline against
    Zhang H; Huang Y; Yu J; Liu X; Ding H
    Front Vet Sci; 2022; 9():975673. PubMed ID: 36157174
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
    Sang K; Hao H; Huang L; Wang X; Yuan Z
    Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.
    Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH
    BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
    Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
    BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
    Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
    J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
    Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
    J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves.
    Balaje RM; Sidhu PK; Kaur G; Rampal S
    Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
    Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
    BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Anaerobic Pharmacokinetic/Pharmacodynamic Model to Simulate the Bactericidal Activity of Levornidazole Against Bacteroides fragilis.
    Hu J; Zhang J; Chen Y; Liang W; Wu S
    Clin Ther; 2017 Apr; 39(4):828-836. PubMed ID: 28363695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
    Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S
    J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Jiang LJ; Xiao X; Yan KX; Deng T; Wang ZQ
    Front Vet Sci; 2022; 9():837882. PubMed ID: 35350432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Model-Informed Drug Development, Pharmacokinetic/Pharmacodynamic Cutoff Value Determination, and Antibacterial Efficacy of Benapenem against
    Ji XW; Xue F; Kang ZS; Zhong W; Kuan IH; Yang XP; Zhu X; Li Y; Lv Y
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.
    Xiao X; Jiang L; Lan W; Jiang Y; Wang Z
    BMC Vet Res; 2018 Nov; 14(1):374. PubMed ID: 30497453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and Pharmacodynamics of Florfenicol in Plasma and Synovial Fluid of Pigs at a Dose of 30 mg/kg
    Somogyi Z; Mag P; Simon R; Kerek Á; Szabó P; Albert E; Biksi I; Jerzsele Á
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107120
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Xiao X; Pei L; Jiang LJ; Lan WX; Xiao JY; Jiang YJ; Wang ZQ
    Front Pharmacol; 2018; 9():391. PubMed ID: 29719510
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.
    Ramalingam B; Sidhu PK; Kaur G; Venkatachalam D; Rampal S
    J Vet Pharmacol Ther; 2015 Dec; 38(6):529-36. PubMed ID: 25776301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.